Expanded to 49 'Innovative Pharmaceutical Companies'... 7 Added Including SK Bioscience

Ministry of Health and Welfare Selects 7 Newly Certified Companies and 5 Companies for Certification Renewal

The Ministry of Health and Welfare announced on the 27th that it has newly certified seven companies through the Innovative Pharmaceutical Company certification review.

Among the 25 companies subject to the new certification review, seven companies including Dong-A ST, Amgen Korea, Onconic Therapeutics, Curecell, HanAll Biopharma, SK Bioscience, and SK Biopharm passed.

Five companies?Alteogen, ABL Bio, Ildong Pharmaceutical, AstraZeneca Korea, and Janssen Korea?were subject to certification renewal review, and all passed. As a result, the total number of companies certified as innovative pharmaceutical companies has expanded to 49.

Since 2012, under the "Special Act on the Promotion and Support of the Pharmaceutical Industry," the Ministry has evaluated companies with a certain level of research and development (R&D) investment and excellent new drug development performance to certify them as innovative pharmaceutical companies. New certifications are conducted every two years, and certification renewals every three years, with the status maintained for three years upon certification.

Companies certified as innovative pharmaceutical companies receive benefits such as additional points when participating in government-supported projects including R&D, preferential drug pricing, tax benefits, and support for regulatory approval.

Jung Eun-young, Director of the Health Industry Policy Bureau at the Ministry of Health and Welfare, said, "Innovative pharmaceutical companies have played an important role in driving the development of the domestic pharmaceutical industry through greater R&D investment compared to general pharmaceutical companies. We will continue to promote support measures and rational system improvements to encourage continuous expansion of R&D investment and the creation of innovative outcomes by innovative pharmaceutical companies."

This content was produced with the assistance of AI translation services.